Compare Moderna, Inc. (MRNA) vs TeraWulf Inc (WULF) Price & Performance

Moderna, Inc.Trade

TeraWulf IncTrade

Price performance (Past 24H)

Key statistics

Moderna, Inc. vs TeraWulf Inc — how do they compare? Moderna, Inc. trades at $59.72 (market cap $23.60B), while TeraWulf Inc trades at $19.98 (market cap $9.35B). The key difference: Moderna, Inc. is far larger — about 2.5× TeraWulf Inc's market cap. Which is the better fit depends on your goals.

	MRNA	WULF
Market Cap	$23.60B	$9.35B
Sector	Health	Technology
52-Week High	$81.80	$28.98
52-Week Low	$22.36	$4.76
Enterprise Value	$19.70B	$12.03B

View details →View details →

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

MRNA

ARKG and GNOM ETFs offer different genomic bets with varied risk and returns in 2026.24/7 Wall Street · 13 hours agoNeutral New report details 1,230+ bioinformatics deals, revealing market trends and deal structures through 2026Researchandmarkets.Com · 4 days agoNeutral View details →

WULF

View details →

About Moderna, Inc.

Moderna, Inc. operates as a clinical stage biotechnology company. The Company focuses on the discovery and development of messenger RNA (mRNA) therapeutics and vaccines. Moderna develops mRNA medicines for infectious, immuno-oncology, and cardiovascular diseases.

About TeraWulf Inc

TeraWulf develops, owns, and operates fully integrated digital infrastructure powered by predominantly zero-carbon energy. It utilizes a hybrid business model that combines industrial-scale Bitcoin mining with high-performance computing (HPC) and AI hosting, leveraging sustainable power sources like nuclear and hydroelectric to deliver low-cost, energy-efficient data center solutions.